Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study
To evaluate the food effect on pharmacokinetics of DHP107 in patients with advanced solid tumors.
Advanced Solid Tumor
DRUG: DHP107(Oral paclitaxel)
• Cmax, The primary endpoints of this trial are the ratio of geometric means of the following pharmacokinetic parameters following DHP107 administration fed with fasting condition, Day 1 and Day 8 of Cycle 1(each cycle is 28 days)|• Tmax, and the median difference of the following pharmacokinetic parameters following DHP107 administration fed with fasting condition:, Day 1 and Day 8 of Cycle 1(each cycle is 28 days)
To evaluate the food effect on pharmacokinetics of DHP107 in patients with advanced solid tumors.